- Country: Poland
- Summary: Successive Delivery of Medicinal Products (Ruksolitinib) for the Implementation of Non-Commercial Clinical Trial "Single-Car Interventional Study with Ruxolitinib and Aieop-Bfm 2017 Chemotherapy in Children ...
- PLT Ref No: 117151801
- Deadline: 05 May 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 216426-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Successive delivery of medicinal products (Ruksolitinib) for the implementation of non-commercial clinical trial "Single-car interventional studklinicznego „Single-arm interventional study with ruxolitinib and AIEOP-BFM 2017 chemotherapy in children with acute lymphoblastic leukemia and confirmed activation of JAK/STAT pathway"
Badanie kliniczne „Single-arm interventional study with ruxolitinib and AIEOP-BFM 2017 chemotherapy in children withacute lymphoblastic leukemia and confirmed activation of JAK/STAT pathway" w ramach projektu "Childhood ALL in Poland (CALL-POL) project: a national harmonization of diagnostics and treatment of acute lymphoblastic leukemia in children"
ruksolitynib 5 mg ; ruksolitynib 20 mg ;
Doc Title: SukcesywnaDelivery of medicinal products (Ruksolitinib) for the implementation of non-commercial clinical trial "Single-Car interventional stud Type:supplies - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSuccessive Delivery of Medicinal Products (Ruksolitinib) for the Implementation of Non-Commercial Clinical Trial "Single-Car Interventional Study with Ruxolitinib and Aieop-Bfm 2017 Chemotherapy in Children ... - Poland Tender
The MEDICAL UNIVERSITY OF LODZ, a Government sector organization in Poland, has announced a new tender for Successive Delivery of Medicinal Products (Ruksolitinib) for the Implementation of Non-Commercial Clinical Trial "Single-Car Interventional Study with Ruxolitinib and Aieop-Bfm 2017 Chemotherapy in Children .... This tender is published on PolandTenders under PLT Ref No: 117151801 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-05.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
